#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13530	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2558	650.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1623	1623	C	834	C	834	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22998	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3961	723.3	0	.	n	.	0	T695C	SNP	695	695	T	1239	1239	C	823	C,T,G	820,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22998	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3961	723.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1881	1881	A	894	A,G,T,C	888,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22998	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3961	723.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2515	2515	C	808	C	808	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22998	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3961	723.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2589	2589	A	770	A,T,G,C	767,1,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22998	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3961	723.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3141	3141	C	859	C,G,T	856,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1958	folP	855	855	100.0	folP.l15.c4.ctg.1	1867	130.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1144	1146	AGC	206;205;207	A;G,T;C	206;203,2;207	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4718	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	4050	145.4	1	SNP	p	S91F	1	.	.	271	273	TTC	858	860	TTC	181;181;179	T;T;C	181;181;179	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4718	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	4050	145.4	1	SNP	p	G95N	0	.	.	283	285	GGC	870	872	GGC	181;180;180	G;G,T;C,A	181;178,1;179,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4718	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	4050	145.4	1	SNP	p	D95G	1	.	.	283	285	GGC	870	872	GGC	181;180;180	G;G,T;C,A	181;178,1;179,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1886	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1652	142.1	1	SNP	p	G45D	0	.	.	133	135	GGC	616	618	GGC	248;245;247	G;G;C	248;245;247	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	992	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1530	80.8	0	.	n	.	0	A197.	DEL	197	197	A	816	816	A	200	A	200	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4486	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3475	161.0	1	SNP	p	D86N	0	.	.	256	258	GAC	884	886	GAC	217;216;213	G;A,T,G;C	217;214,1,1;213	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4486	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3475	161.0	1	SNP	p	S87R	1	.	.	259	261	CGT	887	889	CGT	214;213;215	C;G,T;T,A	214;211,2;214,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4486	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3475	161.0	1	SNP	p	R87I	0	.	.	259	261	CGT	887	889	CGT	214;213;215	C;G,T;T,A	214;211,2;214,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4486	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3475	161.0	1	SNP	p	R87W	0	.	.	259	261	CGT	887	889	CGT	214;213;215	C;G,T;T,A	214;211,2;214,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4486	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3475	161.0	1	SNP	p	S88P	0	.	.	262	264	TCC	890	892	TCC	218;216;218	T,C;C;C	217,1;216;218	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3904	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3014	161.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1766	1768	GGC	213;213;214	G;G;C,T	213;213;213,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3000	144.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1497	1499	GCA	218;222;221	G,C;C,T,A;A,T,G	217,1;220,1,1;219,1,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3000	144.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1500	1502	ATC	222;222;222	A;T;C,T,A	222;222;220,1,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3000	144.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1512	1514	GTG	211;207;206	G;T;G,T	211;207;205,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3000	144.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1512	1514	GTG	211;207;206	G;T;G,T	211;207;205,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3000	144.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2016	2018	ACC	212;211;207	A,T;C,T;C	211,1;210,1;207	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3000	144.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2070	2072	GCG	190;191;191	G;C;G,A	190;191;190,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3000	144.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2070	2072	GCG	190;191;191	G;C;G,A	190;191;190,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3000	144.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2193	2195	AGC	188;187;187	A;G,A;C	188;186,1;187	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3000	144.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2202	2204	GGC	193;191;187	G;G;C,T	192;191;186,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3466	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3000	144.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2220	2222	CCG	195;194;190	C;C;G	195;194;190	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4762	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3540	167.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1863	1865	CCG	188;190;190	C;C,A;G	188;189,1;190	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2098	porA	1146	1146	99.91	porA.l15.c17.ctg.1	2391	109.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	842	842	C	149	C	149	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	156	92.95	porB1a.l15.c17.ctg.3	156	49.7	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	32;34;36	T;T;A	32;34;36	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	156	92.95	porB1a.l15.c17.ctg.3	156	49.7	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	62;62;62	C;A;T	62;62;62	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	156	92.95	porB1a.l15.c17.ctg.3	156	49.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	62;62;62	A;G;T	62;62;62	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	156	92.95	porB1a.l15.c17.ctg.3	156	49.7	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	62;62;62	T;A;C	62;62;62	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2742	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2004	169.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	714	716	GAA	234;236;235	G;A;A,G	234;236;234,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2742	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2004	169.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	1002	1004	GAT	221;220;221	G;A,T;T	221;219,1;221	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2742	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2004	169.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1125	1127	TCA	264;264;263	T,A;C;A	263,1;264;263	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2742	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2004	169.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1254	1256	GTC	224;221;218	G;T,G;C,T,G	224;220,1;216,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2742	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2004	169.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1584	1586	GCA	233;232;234	G;C,A;A,G	233;231,1;231,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2742	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2004	169.7	1	SNP	p	G120K	1	.	.	358	360	AAG	960	962	AAG	217;216;215	A;A,T;G	217;215,1;215	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2742	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2004	169.7	1	SNP	p	D121N	0	.	.	361	363	GAC	963	965	GAC	217;218;218	G;A;C	217;218;218	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2742	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2004	169.7	1	SNP	p	A121D	1	.	.	361	363	GAC	963	965	GAC	217;218;218	G;A;C	217;218;218	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8742	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5262	207.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1360	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1251	133.9	1	SNP	p	V57M	1	.	.	169	171	ATG	642	644	ATG	235;231;229	A;T;G	235;231;229	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
